BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31228011)

  • 21. Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction.
    Rojas SV; Kensah G; Rotaermel A; Baraki H; Kutschka I; Zweigerdt R; Martin U; Haverich A; Gruh I; Martens A
    PLoS One; 2017; 12(5):e0173222. PubMed ID: 28493867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions.
    Garbern JC; Escalante GO; Lee RT
    Trends Cardiovasc Med; 2021 Feb; 31(2):85-90. PubMed ID: 31983535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pluripotent Stem Cells for Cardiac Regeneration - Current Status, Challenges, and Future Perspectives.
    Shiba Y
    Circ J; 2020 Nov; 84(12):2129-2135. PubMed ID: 33087630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human embryonic stem cell-derived cardiomyocyte therapy in mouse permanent ischemia and ischemia-reperfusion models.
    Yu Y; Qin N; Lu XA; Li J; Han X; Ni X; Ye L; Shen Z; Chen W; Zhao ZA; Lei W; Hu S
    Stem Cell Res Ther; 2019 Jun; 10(1):167. PubMed ID: 31196181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts.
    Kadota S; Pabon L; Reinecke H; Murry CE
    Stem Cell Reports; 2017 Feb; 8(2):278-289. PubMed ID: 28065644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Making Cardiomyocytes from Pluripotent Stem Cells.
    Karagiannis P; Yoshida Y
    Methods Mol Biol; 2021; 2320():3-7. PubMed ID: 34302642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
    Kobayashi H; Tohyama S; Ichimura H; Ohashi N; Chino S; Soma Y; Tani H; Tanaka Y; Yang X; Shiba N; Kadota S; Haga K; Moriwaki T; Morita-Umei Y; Umei TC; Sekine O; Kishino Y; Kanazawa H; Kawagishi H; Yamada M; Narita K; Naito T; Seto T; Kuwahara K; Shiba Y; Fukuda K
    Circulation; 2024 Apr; ():. PubMed ID: 38666382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concise Review: Criteria for Chamber-Specific Categorization of Human Cardiac Myocytes Derived from Pluripotent Stem Cells.
    Kane C; Terracciano CMN
    Stem Cells; 2017 Aug; 35(8):1881-1897. PubMed ID: 28577296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of extracellular matrix on engraftment and maturation of pluripotent stem cell-derived cardiomyocytes in a rat myocardial infarct model.
    Ogasawara T; Okano S; Ichimura H; Kadota S; Tanaka Y; Minami I; Uesugi M; Wada Y; Saito N; Okada K; Kuwahara K; Shiba Y
    Sci Rep; 2017 Aug; 7(1):8630. PubMed ID: 28819182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac regeneration using pluripotent stem cells--progression to large animal models.
    Chong JJ; Murry CE
    Stem Cell Res; 2014 Nov; 13(3 Pt B):654-65. PubMed ID: 25087896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction.
    Moon SH; Kang SW; Park SJ; Bae D; Kim SJ; Lee HA; Kim KS; Hong KS; Kim JS; Do JT; Byun KH; Chung HM
    Biomaterials; 2013 May; 34(16):4013-4026. PubMed ID: 23465823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates.
    Liu YW; Chen B; Yang X; Fugate JA; Kalucki FA; Futakuchi-Tsuchida A; Couture L; Vogel KW; Astley CA; Baldessari A; Ogle J; Don CW; Steinberg ZL; Seslar SP; Tuck SA; Tsuchida H; Naumova AV; Dupras SK; Lyu MS; Lee J; Hailey DW; Reinecke H; Pabon L; Fryer BH; MacLellan WR; Thies RS; Murry CE
    Nat Biotechnol; 2018 Aug; 36(7):597-605. PubMed ID: 29969440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive, multiscale framework for evaluation of arrhythmias arising from cell therapy in the whole post-myocardial infarcted heart.
    Yu JK; Franceschi W; Huang Q; Pashakhanloo F; Boyle PM; Trayanova NA
    Sci Rep; 2019 Jun; 9(1):9238. PubMed ID: 31239508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplantation of Pluripotent Stem Cell-Derived Cardiomyocytes into a Myocardial Infarction Model of Cynomolgus Monkey.
    Kobayashi H; Ichimura H; Ohashi N; Shiba Y
    Methods Mol Biol; 2021; 2320():295-302. PubMed ID: 34302666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human Leukocyte Antigen Class I and II Knockout Human Induced Pluripotent Stem Cell-Derived Cells: Universal Donor for Cell Therapy.
    Mattapally S; Pawlik KM; Fast VG; Zumaquero E; Lund FE; Randall TD; Townes TM; Zhang J
    J Am Heart Assoc; 2018 Dec; 7(23):e010239. PubMed ID: 30488760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias.
    Romagnuolo R; Masoudpour H; Porta-Sánchez A; Qiang B; Barry J; Laskary A; Qi X; Massé S; Magtibay K; Kawajiri H; Wu J; Valdman Sadikov T; Rothberg J; Panchalingam KM; Titus E; Li RK; Zandstra PW; Wright GA; Nanthakumar K; Ghugre NR; Keller G; Laflamme MA
    Stem Cell Reports; 2019 May; 12(5):967-981. PubMed ID: 31056479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Label-free identification and characterization of human pluripotent stem cell-derived cardiomyocytes using second harmonic generation (SHG) microscopy.
    Awasthi S; Matthews DL; Li RA; Chiamvimonvat N; Lieu DK; Chan JW
    J Biophotonics; 2012 Jan; 5(1):57-66. PubMed ID: 22083829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trajectory reconstruction identifies dysregulation of perinatal maturation programs in pluripotent stem cell-derived cardiomyocytes.
    Kannan S; Miyamoto M; Zhu R; Lynott M; Guo J; Chen EZ; Colas AR; Lin BL; Kwon C
    Cell Rep; 2023 Apr; 42(4):112330. PubMed ID: 37014753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Large Animal Models in Cardiac Regeneration Research Using Human Pluripotent Stem Cell-Derived Cardiomyocytes.
    Cheng YY; Hu YF; Hsieh PC
    Curr Cardiol Rep; 2023 May; 25(5):325-331. PubMed ID: 37074564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Robust Cardiac Regeneration: Fulfilling the Promise of Cardiac Cell Therapy.
    Selvakumar D; Clayton ZE; Chong JJH
    Clin Ther; 2020 Oct; 42(10):1857-1879. PubMed ID: 32943195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.